Consensus $8.27. Full year organic sales projected to increase 3% to 4% over the prior year, up from previous guidance of 1% to 2%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IEX:
- Is IEX a Buy, Before Earnings?
- Idex Corp. price target lowered to $241 from $244 at Stifel
- IDEX: Cyclical Recovery and Emerging Secular Growth in Fluid Technologies, AI Infrastructure, and Space Communications Support Buy Rating
- Idex Corp. initiated with a Market Perform at BMO Capital
- BMO Capital Maintains Hold on IDEX Amid Solid Fundamentals but Limited Near-Term Upside and Cyclical Exposure
